News & Trends - Pharmaceuticals
Public trust crisis: Government under fire for ethical failures
Almost 40% of Australians report low or no trust in the federal government, while political parties and mainstream news media […]
MoreNews & Trends - Pharmaceuticals
Third generation CAR T therapy to lower neurotoxicity in B-cell lymphoma
Chimeric antigen receptor (CAR) T-cell therapies directed against CD19 and incorporating either CD28 or 4-1BB intracellular co-stimulatory domains are a […]
MoreNews & Trends - Pharmaceuticals
The staggering potential for hep C elimination: A call for political will on World Hepatitis Day
Despite making early headway towards the 2030 hepatitis C elimination goal, recent progress has stalled in Australia. Dr Joss O’Loan, […]
MoreNews & Trends - Pharmaceuticals
Radical overhaul of political donation laws looms ahead of federal election
Greater transparency on donors, donation caps, and limits on campaign expenditure are all on the table as the Australian Electoral […]
MoreNews & Trends - Pharmaceuticals
Keeping pressure as industry awaits government response to HTA Review report
Pharma News: In a bid to keep the momentum, Medicines Australia will host an HTA focused Policy Roundtable with industry […]
MoreNews & Trends - Pharmaceuticals
Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series
In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]
MoreNews & Trends - Pharmaceuticals
Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series
In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]
MoreNews & Trends - Pharmaceuticals
Gilead secures MSAC nod for CAR-T therapy
Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]
MoreNews & Trends - Pharmaceuticals
Critical gaps revealed in post-heart attack drug prescriptions
Pharma News: An Australian-first study highlights significant variations in medication strategies following heart attacks, despite established clinical guidelines intended to […]
MoreNews & Trends - Pharmaceuticals
New class of blood pressure drugs attracts local trial
Pharma News: Approximately half of those prescribed hypertension medications discontinue their use within the first year. Recent clinical trials have […]
MoreRecent Posts in Pharma, MedTech & Biotech
Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research
July 26, 2024
in News & Trends - Biotechnology
NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey
July 26, 2024
in News & Trends - MedTech & Diagnostics
‘To be an inclusive society, we need an embedded national strategy to combat systemic racism’, says Commissioner Sivaraman
July 26, 2024
in Human Resources
Shingles vaccine lowers risk of dementia
July 26, 2024
in News & Trends - Pharmaceuticals
Aussie heart failure technology hits next stage of commercialisation path
July 26, 2024
in News & Trends - MedTech & Diagnostics
Aussie medtech signs new agreement with global orthopaedic company
July 25, 2024
in News & Trends - MedTech & Diagnostics
RMIT University and Telstra Health pioneering risk prediction tool wins national Award
July 25, 2024
in Digital & Innovation
GP elected unopposed as new AMA President, Signals push for primary care reform agenda
July 25, 2024
in Medical
Follow Us
Partner with us
News & Trends - Biotechnology
Aussie biotech secures agreement with UQ and USyd to advance cardiovascular diseases research
Biotech News: Australian biotechnology company, Cartherics, developing immune cell therapies for the treatment of cancer, has entered into a Technology […]
MoreNews & Trends - MedTech & Diagnostics
NSW Health Secretary urges more focus on patient experience, drawing from her own heart valve disease journey
In a heart-warming event that united patients, their loved ones, representatives from patient organisations and employees, Edwards Lifesciences hosted its […]
MoreHuman Resources
‘To be an inclusive society, we need an embedded national strategy to combat systemic racism’, says Commissioner Sivaraman
Race Discrimination Commissioner Giridharan Sivaraman has welcomed the release of the Multicultural Framework Review by the Federal Government, calling it […]
MoreNews & Trends - Pharmaceuticals
Shingles vaccine lowers risk of dementia
Pharma News: A recombinant shingles vaccine which was added to Australia’s National Immunisation Program (NIP) in November last year, is […]
More